Clinical-stage companies have no sales history, but they still have demand. Here’s how to uncover the four streams driving supply planning before material gets tight.
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- CSM Feasibility Begins With Research Strategy And Study Design
- Clinical Supply Systems Need IT General Controls
- AI-Generated Data, Patent Protection, And The Implications For Clinical Supply
- The End Of Just-In-Time? Why Clinical Trial Supply Chains Are Rethinking Inventory Strategy
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Last-Mile Lessons For Depot-To-Site Delivery
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging Processes
Explore how an innovative software platform can be used to create customized, user-friendly applications to digitize clinical secondary packaging processes.
-
Why RTSM Software Doesn't Belong Inside An All-In-One Suite
Don’t let administrative convenience compromise study integrity. Discover why purpose-built RTSM is essential for managing the technical complexities and specialized demands of modern trials.
-
Navigating Audit Trail Data Regulations And Accessibility Changes
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
Ensuring On-Time Release Of CAR-T Cell Treatment In Spain
Due to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
Common RTSM/IRT AN Medication Pooling Questions Answered
Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
How CDMOs Deliver Precision and Scale in Pharma Spray Drying
Spray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
-
Safeguarding Cell Therapy Cryopreservation: Primary Containers
Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.
-
Benefits Of Implementing EDC & Medical Coding With RTSM
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
Building Better Resilience Into Your Clinical Supply Strategy
Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
- Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.